ANAGRELIDE/ ANAGRELIDE B&B/ ANAGRELIDE MEDSURGE/ ANAGRIDE/ ANAGREDEX/ ANAGRELIDE MEDICIANZ (Micro Labs Pty Ltd)
Product name
ANAGRELIDE/ ANAGRELIDE B&B/ ANAGRELIDE MEDSURGE/ ANAGRIDE/ ANAGREDEX/ ANAGRELIDE MEDICIANZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
153 (255 working days)
Active ingredients
anagrelide hydrochloride
Registration type
New generic medicine
Indication
ANAGRIDE capsules are indicated for the treatment of essential thrombocythaemia.
Registration process
First generic
First approval of a medicine that contains the same active ingredient as and is bioequivalent to an existing medicine